Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Sara Bar Yehuda"'
Autor:
Zoya Haitov Ben Zikri, Maryna Volis, Andrei Mazur, Tatjana Orlova, Hana Alon, Sara Bar Yehuda, Vladislav Gofman
Publikováno v:
International Journal of Clinical Practice, Vol 2023 (2023)
Objectives. Most patients who undergo laparoscopic cholecystectomy (LC) experience moderate to severe pain in the first 24 hours after surgery. The transversus abdominal plane (TAP) is currently used for post-LC analgesia. Posterior, subcostal, or re
Externí odkaz:
https://doaj.org/article/5e15571faf82457f80e95b5128752842
Publikováno v:
Health Research Policy and Systems, Vol 17, Iss 1, Pp 1-12 (2019)
Abstract Background Technology adoption in hospitals is usually based on cost-effectiveness analysis, feasibility and potential success. Different countries have embraced a range of principles to accomplish an effective comprehensive process of healt
Externí odkaz:
https://doaj.org/article/8cc408443c4a48a1be400cb927ebb18d
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 7, Iss 1, Pp 85-90 (2005)
NF-κB and the upstream kinase PKB/Akt are highly expressed in chemoresistance tumor cells and may hamper the apoptotic pathway. CF101, a specific agonist to the A3 adenosine receptor, inhibits the development of colon carcinoma growth in cell cultur
Externí odkaz:
https://doaj.org/article/626c3f5b07e24a97995794911a7e891d
Publikováno v:
Health Research Policy and Systems, Vol 17, Iss 1, Pp 1-12 (2019)
Health Research Policy and Systems
Health Research Policy and Systems
Background Technology adoption in hospitals is usually based on cost-effectiveness analysis, feasibility and potential success. Different countries have embraced a range of principles to accomplish an effective comprehensive process of health technol
Autor:
Shira Cohen, Faina Barer, Sara Bar-Yehuda, Adriaan P. IJzerman, Kenneth A. Jacobson, Pnina Fishman
Publikováno v:
Mediators of Inflammation, Vol 2014 (2014)
The A3 adenosine receptor (A3AR) is overexpressed in inflammatory cells and in the peripheral blood mononuclear cells of individuals with inflammatory conditions. Agonists to the A3AR are known to induce specific anti-inflammatory effects upon chroni
Externí odkaz:
https://doaj.org/article/0677634340754e048807810c00a0fc97
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 3, Iss 2, Pp 125-131 (2001)
Tumor metastases are extremely rare in striated muscles. Lately, we have found that muscle cell conditioned medium (MCM) inhibits the proliferation of various tumor cells while maintaining the growth of normal murine bone marrow cells. This dual acti
Externí odkaz:
https://doaj.org/article/e97b266c893a4586bb23bd9cb7743189
Publikováno v:
Drug Discovery Today. 17:359-366
The A(3) adenosine receptor (A(3)AR) coupled to G(i) (inhibitory regulative guanine nucleotide-binding protein) mediates anti-inflammatory, anticancer and anti-ischemic protective effects. The receptor is overexpressed in inflammatory and cancer cell
Autor:
Henk de Vries, Sara Bar-Yehuda, Thea Mulder-Krieger, Jacobien K. Von Frijtag Drabbe Künzel, Pnina Fishman, Clara C. Blad, Adriaan P. IJzerman
Publikováno v:
Purinergic Signalling
We tested a panel of naturally occurring nucleosides for their affinity towards adenosine receptors. Both N6-(2-isopentenyl)adenosine (IPA) and racemic zeatin riboside were shown to be selective human adenosine A3 receptor (hA3R) ligands with affinit
Autor:
Noa Chetrit, Pnina Fishman, William D Kerns, Kenneth A. Jacobson, Irina S. Barequet, Motti Farbstein, Sara Bar Yehuda, Hanna J. Garzozi, Gil Sartani, Michael H. Silverman, Gilad Litvin, Erez Bakshi, Oren Tomkins, David Zadok, Ilan Cohn, Zivit Harpaz, Fanni Segev, David Bristol, Sari Fishman, David Varssano, Isaac Avni
Publikováno v:
Ophthalmology. 117:1287-1293
Objective To explore the safety and efficacy of CF101, an A 3 adenosine receptor agonist, in patients with moderate to severe dry eye syndrome. Design Phase 2, multicenter, randomized, double-masked, placebo-controlled, parallel-group study. Particip
Autor:
Avivit Ochaion, Lea Rath-Wolfson, R. Patoka, Sara Bar-Yehuda, L. Del Valle, D. Castel, G. Zozulya, Sergio Pina-Oviedo, P. Fishman, Shira Cohen, E. Atar, G. Perez-Liz, Faina Barer
Publikováno v:
Arthritis & Rheumatism. 60:3061-3071
Objective Studies have suggested that rheumatoid arthritis (RA) and osteoarthritis (OA) share common characteristics. The highly selective A3 adenosine receptor agonist CF101 was recently defined as a potent antiinflammatory agent for the treatment o